These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38615429)

  • 1. Derivatization-free determination of chiral plasma pharmacokinetics of MDMA and its enantiomers.
    Luethi D; Rudin D; Straumann I; Thomann J; Avedisian I; Liechti ME; Duthaler U
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 May; 1238():124123. PubMed ID: 38615429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of an LC-MS/MS method after chiral derivatization for the simultaneous stereoselective determination of methylenedioxy-methamphetamine (MDMA) and its phase I and II metabolites in human blood plasma.
    Steuer AE; Schmidhauser C; Liechti ME; Kraemer T
    Drug Test Anal; 2015 Jul; 7(7):592-602. PubMed ID: 25371386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for enantioselective measurement of the designer drugs MDEA, MDMA, and MDA and its application to samples from a controlled study with MDMA.
    Peters FT; Samyn N; Lamers CT; Riedel WJ; Kraemer T; de Boeck G; Maurer HH
    Clin Chem; 2005 Oct; 51(10):1811-22. PubMed ID: 16099938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chiral analysis of amphetamine, methamphetamine, MDMA and MDA enantiomers in human hair samples.
    Bickel J; Szewczyk A; Aboutara N; Jungen H; Müller A; Ondruschka B; Iwersen-Bergmann S
    J Anal Toxicol; 2024 May; 48(4):226-234. PubMed ID: 38613438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its phase-1 metabolites in human biological fluids.
    Lo Faro AF; Sprega G; Beradinelli D; Tini A; Poyatos L; Papaseit E; Berretta P; Di Giorgi A; Farre M; Takaishvili N; Farkas T; Busardò FP; Chankvetadze B
    J Pharm Biomed Anal; 2024 Jan; 238():115768. PubMed ID: 37979525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis.
    Pizarro N; Ortuño J; Farré M; Hernández-López C; Pujadas M; Llebaria A; Joglar J; Roset PN; Mas M; Segura J; Camí J; de la Torre R
    J Anal Toxicol; 2002 Apr; 26(3):157-65. PubMed ID: 11991532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantioselective separation and determination of miconazole in rat plasma by chiral LC-MS/MS: application in a stereoselective pharmacokinetic study.
    Du Y; Luo L; Sun S; Jiang Z; Guo X
    Anal Bioanal Chem; 2017 Nov; 409(27):6315-6323. PubMed ID: 28852798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chiral separation of 3,4-methylenedioxymethamphetamine (MDMA) enantiomers using batch chromatography with peak shaving recycling and its effects on oxidative stress status in rat liver.
    Lourenço TC; Bósio GC; Cassiano NM; Cass QB; Moreau RL
    J Pharm Biomed Anal; 2013 Jan; 73():13-7. PubMed ID: 22342062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereospecific analysis and enantiomeric disposition of 3, 4-methylenedioxymethamphetamine (Ecstasy) in humans.
    Fallon JK; Kicman AT; Henry JA; Milligan PJ; Cowan DA; Hutt AJ
    Clin Chem; 1999 Jul; 45(7):1058-69. PubMed ID: 10388483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A validated enantioselective LC-MS/MS assay for quantification of a major chiral metabolite of an achiral 11-β-hydroxysteroid-dehydrogenase 1 inhibitor in human plasma: Application to a clinical pharmacokinetic study.
    Furlong MT; Ji QC; Iacono L; Dang O; Noren M; Bruce J; Aubry AF; Arnold ME
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():167-172. PubMed ID: 27100678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enantioselective determination of ketamine in dog plasma by chiral liquid chromatography-tandem mass spectrometry.
    Li R; Zhong K; Jiang J; Zhan Y; Chen X
    Biomed Chromatogr; 2019 Sep; 33(9):e4578. PubMed ID: 31077428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) stereoisomers in a fatal poisoning.
    Moore KA; Mozayani A; Fierro MF; Poklis A
    Forensic Sci Int; 1996 Dec; 83(2):111-9. PubMed ID: 9022274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of LC-HRMS and GC-NICI-MS methods for stereoselective determination of MDMA and its phase I and II metabolites in human urine.
    Schwaninger AE; Meyer MR; Huestis MA; Maurer HH
    J Mass Spectrom; 2011 Jul; 46(7):603-14. PubMed ID: 21656610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enantioselective determination of ornidazole in human plasma by liquid chromatography-tandem mass spectrometry on a Chiral-AGP column.
    Du J; Ma Z; Zhang Y; Wang T; Chen X; Zhong D
    J Pharm Biomed Anal; 2013 Dec; 86():182-8. PubMed ID: 24004635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of human hepatic cytochrome P450 isozymes in the metabolism of racemic 3,4-methylenedioxy-methamphetamine and its enantiomers.
    Meyer MR; Peters FT; Maurer HH
    Drug Metab Dispos; 2008 Nov; 36(11):2345-54. PubMed ID: 18725511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative determination of ondansetron in human plasma by enantioselective liquid chromatography-tandem mass spectrometry.
    Liu K; Dai X; Zhong D; Chen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Mar; 864(1-2):129-36. PubMed ID: 18299256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its phase-1 metabolites in human biological fluids.
    Sprega G; Kobidze G; Lo Faro AF; Pichini S; Farkas T; Tini A; Mskhiladze A; Busardò FP; Chankvetadze B
    J Pharm Biomed Anal; 2024 Jun; 243():116076. PubMed ID: 38430614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous enantiomeric determination of MDMA and its phase I and phase II metabolites in urine by liquid chromatography-tandem mass spectrometry with chiral derivatization.
    Nakanishi K; Katagi M; Zaitsu K; Shima N; Kamata H; Miki A; Kato H; Harada K; Tsuchihashi H; Suzuki K
    Anal Bioanal Chem; 2012 Nov; 404(8):2427-35. PubMed ID: 23010844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chiral separation and quantification of R/S-amphetamine, R/S-methamphetamine, R/S-MDA, R/S-MDMA, and R/S-MDEA in whole blood by GC-EI-MS.
    Rasmussen LB; Olsen KH; Johansen SS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Oct; 842(2):136-41. PubMed ID: 16797258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of darusentan enantiomers in rat plasma by enantioselective liquid chromatography with tandem mass spectrometry using cellulose-based chiral stationary phase.
    Gu J; Shi X; Du Y; Wang W; Du X; Zhang L
    J Sep Sci; 2011 Oct; 34(19):2680-5. PubMed ID: 21823235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.